72 GHP Healthcare & Pharma Awards 2023 Feellife Health Inc’s (Feellife) one-stop solution service for global nebulizer and nebulizer liquid ecology offers a comprehensive, high-tech, industry integrating solution, complete with research and development, production, sales, service, and academics of nebulized products and nebulized vaccine equipment. We find out more as the firm celebrates a win in the Healthcare and Pharmaceutical Awards 2023. Established in 2013, Feellife Health Inc stands tall as a globally renowned pioneer in medical nebulization. Feellife has invented microwave and frequency conversion nebulizer technology and mastered the core 220+ patents. Central to its innovation is AiMesh®, the bedrock of advanced mesh nebulizer tablets shaping the industry landscape. Self-developed breakthrough AiMesh®+ polymer diaphragm enables the nebulized particle size to be adjusted to the drug parameters to ensure optimum preventive or therapeutic effect, whilst the material is bio-elastic and does not crack easily under vibration. This breakthrough drives Feellife’s nebulization solutions to the forefront of the industry. The nebulized inhalation vaccine solves the inconvenience of needing to concentrate people, time, and place for injections, and the risks to provinces, cities, and counties in terms of operation, safety, and crossinfection, in addition to being concentrated in social health promotion. The vaccine is nebulized into tiny particles with a nebulizer, and enters the respiratory tract mucosa through inhalation, thereby stimulating the mucosal immune response, which cannot be brought by intramuscular injection. Immunization using nebulized inhalation is painless and requires less targeted drug delivery. The latest clinical trial by Chen Wei, an academician of Chinese Academy of Sciences, shows that only onefifth of the injection dose is required, and the compliance is high. This finding shows that aerosol vaccinations can induce a higher ratio of neutralizing antibodies to total antibody than the intramuscular injection. Feellife owns more than 250 patents and international invention patents, and applies its core patent Aimesh to its self-developed nebulization solutions, including eye nebulization, upper and lower respiratory nebulization, nasal nebulization, and other human organ nebulization treatment solutions. Recently, through pioneering inverter and quantitative nebulization technologies, Feellife’s reputation has once again soared, capturing the attention and accolades of pharmaceutical giants and the medical device sector. Within the realm of professional-grade medical nebulization, the Feellife AirICU Max+ has solidified its status as the preferred choice for doctors and patients alike. Recognising Feellife’s leadership, Global Health & Pharma has honored the firm with the prestigious Best Nebulized Vaccine Equipment Specialists 2023 title in the Healthcare and Pharmaceutical Awards 2023. Venturing into uncharted territory, Feellife has partnered with the VPLUS brand to introduce a revolutionary nicotine alternative solution. This visionary approach leverages the patented AiMesh® and Renico® technologies, redefining nicotine consumption for smokers. Utilizing Feellife’s exclusive Renico® synthetic nicotine technology ensures VPLUS users are shielded from harmful components like Propylene Glycol and Vegetable Glycerin. With chemical additives eliminated and pure plant extraction embraced, this advancement not only prioritizes user well-being but also charts a path towards a secondhand-smoke-free world. Another milestone has been reached as Feellife collaborates with Cannapresso, a preeminent solution provider in the U.S. CBD industry. By harnessing advanced medical research and development capabilities, Feellife is poised to enhance the Cannapresso CBD ingredient formulas. This includes elements like delta-8 THC, known for its positive impact on user wellness, serenity, and antidepressant properties. By integrating AiMesh® into Cannapresso hardware, Feellife champions the health potential of the CBD space, aiming to elevate the well-being of CBD consumers. In essence, Feellife Health Inc remains unwavering in its pursuit of a transformative vision: “Feellife – The Third Way of Dosing”. Through innovation, strategic partnerships, and a steadfast commitment to global health, Feellife reshapes industries, empowers individuals, and charts a course towards a brighter future. Contact Details Company: Feellife Health Inc. Web Address: www.feellife.com Best Nebulised Vaccine Equipment Specialists 2023 Jul23630
RkJQdWJsaXNoZXIy MTUyMDQwMA==